Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTIPAF: Olmesartan in Paroxysmal Atrial Fibrillation
NCT00098137Phase 3Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Jan 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of olmesartan in Atrial fibrillation (AFib), sponsored by Kompetenznetz Vorhofflimmern. Started Jan 2005; status: completed.
02
Drugs
olmesartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00098137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098137.